newsfilter
← Latest News
PR Newswire·

Sorrento Therapeutics, Inc. Receives Court Approval for $75 Million Financing in Chapter 11 Case

SAN DIEGO, Feb. 21, 2023 /PRNewswire/ -- Sorrento Therapeutics, Inc. (NASDAQ:SRNE, ", Sorrento", )), a biopharmaceutical company dedicated to the development of life-saving therapeutics to treat cancer, intractable